Jefferies Initiates Coverage on Evolent Health Inc(NYSE:EVH). The shares have been rated Buy. The rating by Jefferies was issued on Jul 26, 2016.
Evolent Health Inc (EVH) made into the market gainers list on Fridays trading session with the shares advancing 0.77% or 0.18 points. Due to strong positive momentum, the stock ended at $23.54, which is also near the day’s high of $23.55. The stock began the session at $23.45 and the volume stood at 2,23,973 shares. The 52-week high of the shares is $25 and the 52 week low is $8.14. The company has a current market capitalization of $1,415 M and it has 6,00,94,615 shares in outstanding.
Evolent Health Inc(EVH) last announced its earnings results on May 12, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $49.54M. Analysts had an estimated revenue of $47.40M. Earnings per share were $-0.16. Analysts had estimated an EPS of $-0.19.
Several Insider Transactions has been reported to the SEC. On Jun 10, 2015, Gary Piefer (Chief Medical Officer) purchased 2,000 shares at $17.00 per share price.
Evolent Health Inc. is engaged in the healthcare delivery and payment markets. The Company’s platform enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to value-based payment models. It provides an end-to-end technology-enabled services platform for providers to transition their organization in value-based payment models. It markets and sells services to providers throughout the United States. The Company works with its partners in two phases. In the transformation phase it works with its partners to develop a plan for their transition to a value-based care model. During the second portion of the transformation phase the Company works with its partner to implement the Blueprint. During the transformation phase the Company seeks to enter into long-term agreements with its partners. In the platform and operations phase the Company establishes a local market presence and embeds its resources alongside the Company’s partners.